New data on Helsinn's oncology pipeline presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

China ,Australia ,Lugano ,Ticino ,Switzerland ,Ireland ,United States ,Canada ,American ,Igor Odintsov ,Paola Bonvicini ,Sergio Cantoreggi ,Gastroenterol Hepatol ,Subbiahv Cote ,European Network For The Study Of Cholangiocarcinoma ,American Society Of Clinical Oncology ,Helsinn Group ,Weill Cornell Medical College ,Helsinn Birex Pharmaceuticals Ltd ,Group Head Of Communication ,Co Glob Oncol ,Memorial Sloan Kettering Cancer Center ,American Society ,Clinical Oncology ,Annual Meeting ,Fully Integrated Target Therapy ,Preclinical Disease Models ,Memorial Sloan Kettering Cancer ,Central Nervous System ,Weill Cornell Medical ,Gastrointestinal Cancer ,Helsinn Group Chief Scientific Officer ,Fullyintegrated Targeted Therapystrategy ,Helsinn Birex Pharmaceuticals ,Taiho Pharmaceutical ,Important Safety Information ,Prescribing Information ,Patient Medication Information ,Product Information ,Cancer Ther ,Genomic Analysis ,Cholangiocarcinoma Identifies Distinct ,Mutant Molecular ,Cell Rep ,Quan Lim ,Endemic Fluke Associated ,European Network ,Nat Rev Gastroenterol Hepatol ,Rev Gastroenterol Hepatol ,Media Contact ,Health ,Globe Newswire ,Tumors ,